Clinical Services > Pain management

Cannabis: short-term gain, but long-term pain?

07 June, 2022

US researchers have reviewed 25 trials and studies to evaluate the benefits and harms of cannabinoids for chronic pain.


CBD: very high doses don't affect driving, cognition

01 June, 2022

Cannabidiol use seems to be increasing, with a recent University of Sydney study showing around 55,000 requests to access medicinal CBD approved since 2016.


More than 1800 drug-induced deaths in 2020: report

30 May, 2022

In 2020, drug-induced deaths were nearly twice as frequent among males as females, according to a new report by the National Drug and Alcohol Research Centre.


Dry eye: 77% Australians experience symptoms but many unaware

25 May, 2022

Despite the discomfort, only 11% of people would see an optometrist and only around 3% would speak to a pharmacist for advice.


248K medicinal cannabis scripts approved

10 May, 2022

Around 248,000 medicinal cannabis scripts have been approved in Australia since 2016, and the drug is increasingly prescribed for various conditions, reveals a new study.


New opioids standard encourages alternatives, cessation plans

28 April, 2022

The Australian Commission on Safety and Quality in Health Care has launched a new national standard for opioid analgesics to help prevent long-term harm.


New drug study hopes to help kids with severe epilepsy

10 February, 2022

Researchers from the University of South Australia are working with European researchers to investigate a range of FDA-approved drugs with an aim to help kids with severe epilepsy.


New medicines agreements a boost for supply, sustainability: SHPA

08 September, 2021

The SHPA has welcomed the medicines agreements as vital to protecting patients against shortages and ensuring medicines are accessible, available and cost-efficient.


New standard for opioid analgesics

01 September, 2021

The Australian Commission on Safety and Quality in Health Care is seeking comments on the draft clinical care standard for opioid analgesics.


Opioid overuse: Australia needs national strategy

04 August, 2021

Australia needs a comprehensive, coordinated approach to overdose prevention by national and state governments and professional groups.


Infant pain-monitoring device gains international approval

28 May, 2021

The smartphone-based pain assessment application has potential for use in children's hospitals, in postnatal wards, and among parents and other healthcare professionals.


Last chance for aged-care providers to claim free PainChek licence

20 May, 2021

This fortnight is the last chance for aged-care facilities to participate in the government-subsidised rollout of a complete point-of-care solution for best practice pain management.


Tech restores lives of those in chronic pain

19 May, 2021

The Avalon Study has demonstrated the life-changing benefits of a closed-loop spinal cord stimulation system in patients with chronic, intractable pain.


NSAIDs and pharmacists vital in low back pain management

28 April, 2021

Patients with low back pain have been shown to respond well to NSAIDs such as ibuprofen, according to researchers at RMIT University.


Device blocks the pain of shots

14 April, 2021

ShotBlocker is a non-invasive solution that has been shown to reduce or remove pain in 93.2% of users at half the cost of topical freezing sprays and anaesthetic creams.


  • All content Copyright © 2022 Westwick-Farrow Pty Ltd